| Ryan Thomas Pulvermacher, | |
|
800 Riverside Dr, Waupaca, WI 54981-1943 | |
| (715) 258-1053 | |
| Not Available |
| Full Name | Ryan Thomas Pulvermacher |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapist |
| Location | 800 Riverside Dr, Waupaca, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477259828 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 8209 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Thomas Pulvermacher, 3 Neenah Ctr, Neenah, WI 54956-3070 Ph: (715) 258-1053 | Ryan Thomas Pulvermacher, 800 Riverside Dr, Waupaca, WI 54981-1943 Ph: (715) 258-1053 |
News Archive
Discovery of an antibiotic's capacity to improve cell function in laboratory tests is providing movement disorder researchers with leads to more desirable molecules with potentially similar traits, according to University of Alabama scientists co-authoring a paper publishing March 10 in the journal Disease Models & Mechanisms.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced the results of a study evaluating the activity of elesclomol against acute myeloid leukemia (AML) cell lines and primary leukemic blast cells from AML patients, presented at the Annual Meeting of the American Society of Hematology (ASH) in New Orleans.
Microglia - the brain's immune cells - play a primary role in removing cellular debris from the brain. According to a recent study by a Nagoya University-led research team in Japan, another kind of brain cell, called astrocyte, is also involved in removing debris as a backup to microglia.
Genovate Biotechnology Co. Ltd. and ScinoPharm Taiwan Ltd. announced today that they have jointly developed the highly potent oral generic drug Livepro (Entecavir), representing a new generation of drugs for the treatment of Hepatitis B. It is expected to be commercially available by the end of the year in Taiwan, accounting for more than NT$2 billion (US$70 million) worth of market opportunity.
Candida albicans is a double agent: In most of us, it lives peacefully, but for people whose immune systems are compromised by HIV or other severe illnesses, it is frequently deadly. Now a new study from Johns Hopkins and Harvard Medical School shows how targeting a specific fungal component might turn the fungus from a lion back into a kitten.
› Verified 3 days ago
Amanda Debauche, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 Riverside Dr, Waupaca, WI 54981 Phone: 715-258-1053 | |
Mrs. Tracy Marie Darnutzer, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1226 Berlin St, Waupaca, WI 54981 Phone: 715-942-1422 | |
Lamont Parrott, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 Riverside Dr, Waupaca, WI 54981 Phone: 715-258-1053 Fax: 715-258-1153 | |
Meghan Renee Halambeck, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1226 Berlin St, Waupaca, WI 54981 Phone: 262-622-3964 | |
Ms. Sue Laurie Young, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1401 Churchill St, Waupaca, WI 54981 Phone: 715-258-8131 Fax: 715-258-0179 | |
Mrs. Anne Theresa Lieber, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 811 Harding St, Waupaca, WI 54981 Phone: 715-258-6337 |